GPA33 and cancer: GPA33 and Claudin 18.2 exhibit statistically significant mutually exclusive expression in cancer tissue cores; 36% of cancers are GPA33<sup>+</sup>/Claudin 18.2<sup>-</sup>, whilst 22% are GPA33<sup>-</sup>/Claudin 18.2<sup>+</sup>.